RespireRx Pharmaceuticals Inc. - FORM S-1/A - EX-23.1 - CONSENT OF HASKELL & WHITE LLP - September 7, 2011

Attached files

file filename
S-1/A - AMENDMENT NO. 1 TO FORM S-1 - RespireRx Pharmaceuticals Inc.ds1a.htm
EX-4.5 - FORM OF WARRANT - RespireRx Pharmaceuticals Inc.dex45.htm
EX-1.1 - FORM OF PLACEMENT AGENCY AGREEMENT - RespireRx Pharmaceuticals Inc.dex11.htm
EX-5.1 - OPINION OF STRADLING YOCCA CARLSON & RAUTH - RespireRx Pharmaceuticals Inc.dex51.htm
EX-1.2 - FORM OF PURCHASE AGREEMENT - RespireRx Pharmaceuticals Inc.dex12.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Amendment No. 1 to the Registration Statement of Cortex Pharmaceuticals, Inc. (“Company”) on Form S-1 of our report dated March 18, 2011, which includes an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern, appearing in the Prospectus, which is part of this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Prospectus.

 

/s/ Haskell & White LLP
HASKELL & WHITE LLP

September 7, 2011

Irvine, CA

RespireRx Pharmaceuticals Inc. Reports